Search Results

• Book

  Adverse Events and Oncotargeted Kinase Inhibitors

  Giuseppe Tridente.

  Contents:
  Introduction
  Kinases
  Kinase inhibitors
  Adverse events
  Imantinib
  Gefitinib
  Erlotinib
  Sorafenib
  Sunitinib
  Dasatinib
  Lapatinib
  Nilotinib
  Pazopanib
  Vandetanib
  Vemurafenib
  Crizotinib
  Ruxolitinib
  Axitinib
  Bosutinib
  Regorafenib
  Cabozantinib
  Ponatinib
  Dabrafenib
  Trametinib
  Afatinib
  Idelaisib
  Ibrutinib
  Overview
  Conclusion and perspectives.

  Digital Access 2017
  Get Shareable Link

  View Details